Buzz in Pharma Blogs This Week Includes Pfizer HIV Marketers Getting Fired, FDA’s Hearing on Avandia, and Blogger Peter Rost is Taking Over for Journalist Jim Edwards at Brandweek NRX
NEWTOWN, PA, August 6, 2007 – Blogger Peter Rost has been hired by mainstream media to replace a journalist, three executives at Pfizer have been fired over alleged improper marketing activities for HIV drugs maraviroc and Viracept, GlaxoSmithKline’s diabetes drug Avandia survived the FDA committee hearing, and J&J is taking cost-cutting measures by eliminating 3% to 4% of its work force. Christiane Truelove, editor of Med Ad News and R&D Directions, summarizes the thoughts of popular industry bloggers on these and other topics in this week’s PharmaBlogs: Week in Review eNewsletter.
Some of Ms. Truelove’s highlights in this eNewsletter:
- Dr. Peter Rost interviews Christiane Truelove herself and plugs the PharmaBlogs: Week in Review eNewsletter.
- Ed Silverman at PharmaLot says of Dr. Rost’s new post, “Rost is being given an even wider, credible platform to follow pharma. This will, no doubt, drive more than a few people inside Pfizer, and some other companies, a little crazy. But for the rest of us, it should be interesting.”
- Dr. Daniel Carlat of Carlat Psychiatry Blog comments about Pfizer’s marketing firings saying, “When your marketing plan is always teetering on the edge of corruption, you’re gonna get burned.”
- Dr. Derek Lowe of In the Pipeline believes that FDA’s decision on Avandia was well done and “grown up.”
Read more about these and other topics covered this week by subscribing to the PharmaBlogs: Week in Review eNewsletter. Visit www.pharmalive.com/enewsletters.
About PharmaBlogs: Week in Review
Designed as a time-effective approach to keeping current on the industry’s blog discussions, PharmaBlogs: Week in Review is the first online newsletter focused on recapping pharmaceutical blogs. The e-newsletter is published by industry information provider Engel Publishing Partners and sent to your e-mail inbox each Friday.
About Engel Publishing Partners
For 25 years, Engel Publishing Partners has been the source that pharmaceutical executives turn to for the information they need to create competitive business strategies. Engel Publishing Partners carries a full product line, offering industry-leading publications Med Ad News and R&D Directions, informative newsletters, and data-rich interactive products. Through these channels, Engel Publishing Partners disseminates original and un-biased content that provides insight into industry trends and events, as well as extensive analysis of companies, products, and pipelines.
215-0867-0044 x 248
Posted: August 2007